Research has shown that SEPT9 methylation is linked to the pathophysiology of colorectal cancer (CRC), and that a decline in SEPT9 expression is connected with the advancement of neoplastic illness (74). The gene discussed is SEPTIN9; the disease is colorectal carcinoma.